SciELO - Scientific Electronic Library Online

 
vol.135 número4Subdiagnóstico de restricción de crecimiento fetal mediante la aplicación de las curvas de crecimiento intrauterino del Ministerio de SaludDescripción del consumo de drogas lícitas e ilícitas por género a través de la metodología de pares índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Revista médica de Chile

versión impresa ISSN 0034-9887

Resumen

GAGGERO, Aldo et al. Seroprevalence of IgG antibodies against parvovirus B19 among blood donors from Santiago, Chile. Rev. méd. Chile [online]. 2007, vol.135, n.4, pp.443-448. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872007000400005.

Background: Parvovirus B19 (B19) is associated with a wide range of disease manifestations, whose severity depends on the immunological and hematological status of the host. Infection with B19 has been reported worldwide and the prevalence of immunoglobulin G antibodies against B19 increases with age and varies by location and time of the last B19 epidemic. Aim: To evaluate the prevalence of IgG antibodies against Parvavirus B19 virus in a population of volunteer blood donors at two hospital blood banks in Santiago, Chile. Material and Methods: A total of 400 serum samples from blood donors aged 18 to 65 years, were examined for the presence of IgG antibodies against Parvovirus B19. Results: The overall prevalence of IgG antibodies was 54.8%. No significant difference was found between men and women (57.6% and 49.3%, respectively). Conclusions: IgG antibody seroprevalence against Parvovirus B19, was 55% in this sample of Chilean blood donors. This figure is in agreement with previous reports from abroad

Palabras clave : Blood donors; Immunoglobulin G; Parvovirus B19, human.

        · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons